FeCl3 vessel occlusion within 5 minutes of FeCl3 application in AAV-mFVIIa, AAV-mFVIIa-VEAY or untreated HA mice
| Mouse group . | Mice with full occlusion (%) within 5 minutes . | Mice with no occlusion (%) . |
|---|---|---|
| AAV-mFVIIa* (n = 9) | 3 (33%) | 4 (45%) |
| AAV-mFVIIa-VEAY (n = 9) | 3 (33%) | 6 (67%) |
| HA, untreated (n = 11) | 0 (0%) | 11 (100%) |
| Mouse group . | Mice with full occlusion (%) within 5 minutes . | Mice with no occlusion (%) . |
|---|---|---|
| AAV-mFVIIa* (n = 9) | 3 (33%) | 4 (45%) |
| AAV-mFVIIa-VEAY (n = 9) | 3 (33%) | 6 (67%) |
| HA, untreated (n = 11) | 0 (0%) | 11 (100%) |
Number of mice (n) is indicated for each group.
Two mice showed partial occlusion at 5-6 minutes after FeCl3 application.